mosunetuzumab

Italy

Drugs containing this active substance

  • LUNSUMIO

    Lunsumio is an anticancer medicinal product used for the treatment of adults with follicular lymphoma (FL), a type of blood cancer that affects B cells.

    Form: solution for injection for infusion concentrate

    Active substance Dosage
    mosunetuzumab -

    ATC: L01FX25

    Manufacturer: ROCHE REGISTRATION GMBH